Glenn L MD Cooper's Net Worth
$9.13 Million
Who is Glenn L MD Cooper?
Glenn L MD Cooper has an estimated net worth of $9.13 Million. This is based on reported shares across multiple companies, which include REPLIGEN CORP, CORONADO BIOSCIENCES INC, and INDEVUS PHARMACEUTICALS INC.
SEC CIK
Glenn L MD Cooper's CIK is 0001046351
Past Insider Trading and Trends
2012 was Glenn L MD Cooper's most active year for acquiring shares with 7 total transactions. Glenn L MD Cooper's most active month to acquire stocks was the month of April. 2019 was Glenn L MD Cooper's most active year for disposing of shares, totalling 5 transactions. Glenn L MD Cooper's most active month to dispose stocks was the month of April. 2004 saw Glenn L MD Cooper paying a total of $7,637,600.00 for 1,370,000 shares, this is the most they've acquired in one year. In 2004 Glenn L MD Cooper cashed out on 1,220,000 shares for a total of $6,749,600.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REPLIGEN CORP (RGEN) Snapshot price: $147.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +46.67% | 19K |
$35.97 | -$214,714.92 | 59.71K |
May 23
| |||
Form 4
| -12.28% | -5.00K |
$66.94 | -$334,714.92 | 35.71K |
May 23
| |||
Form 4
| +2.32% | 923 |
—
|
—
| 40.71K |
May 15
| |||
Form 4
| +3.88% | 1.49K |
—
|
—
| 39.79K |
May 16
| |||
Form 4
| +3.25% | 1.21K |
—
|
—
| 38.3K |
May 18
| |||
Form 4
| +4.99% | 1.76K |
—
|
—
| 37.09K |
May 11
| |||
Form 4
| +2.91% | 1K |
$26.56 | $26,563.50 | 35.33K |
Nov 9
| |||
Form 4
| +3.06% | 1.02K |
—
|
—
| 34.33K |
May 21
| |||
Form 4
| +6.16% | 1.93K |
—
|
—
| 33.31K |
May 15
| |||
Form 4
| +20.52% | 5.34K |
—
|
—
| 31.38K |
May 9
| |||
Form 4
| +62.35% | 10K |
$6.09 | $60,874.10 | 26.04K |
Sep 21
| |||
Form 4
| +220.76% | 11.04K |
—
|
—
| 16.04K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
∞
| 5K |
$4.98 | $24,900.00 | 5K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORONADO BIOSCIENCES INC (FBIO) Snapshot price: $1.79
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.53% | 3.81K |
$4.02 | $15,320.22 | 43.81K |
Nov 30
| |||
Form 4
| +33.33% | 10K |
$5.30 | $52,968.00 | 40K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INDEVUS PHARMACEUTICALS INC No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -467.09K |
—
|
—
|
0
|
Feb 23 - Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
| +51.21% | 158.19K |
—
|
—
| 467.09K |
Sep 25
| |||
Form 4
| +15.74% | 42K |
—
|
—
| 308.9K |
Oct 30
| |||
Form 4
| +36.87% | 71.9K |
—
|
—
| 266.9K |
Mar 7
| |||
Form 4
| +5.41% | 10K |
$5.85 | $58,500.00 | 195K |
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +5.71% | 10K |
$4.05 | $40,500.00 | 185K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
| No matching records found | |||||||||